Manufacturer
Genzyme
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 23
- Molecules
- 16
- Therapy areas
- 6
Genzyme is a pharmaceutical manufacturer based in United States. MedsAcross lists 23 of its products across 16 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Genzyme Corporation
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Genzyme products through licensed channels, with the documents your regulator needs.
Rare diseases and enzyme replacement
8 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Aldurazyme 2.9 mg/5 mL injectionIntravenous Cold chain | Laronidase | US FDA | Available on request |
| Cerdelga 84 mg capsuleOral | Eliglustat | US FDA | Available on request |
| Cerezyme 40 units/mL powder for injectionIntravenous Cold chain | Imiglucerase | US FDA | Available on request |
| Fabrazyme 5 mg/mL powder for injectionIntravenous Cold chain | Agalsidase beta | US FDA | Available on request |
| Lumizyme 5 mg/mL powder for injectionIntravenous Cold chain | Alglucosidase alfa | US FDA | Available on request |
| Nexviazyme 100 mg/10 mL powder for injectionIntravenous Cold chain | Avalglucosidase alfa | US FDA | Available on request |
| Xenpozyme 20 mg/5.1 mL powder for injectionIntravenous Cold chain | Olipudase alfa | US FDA | Available on request |
| Xenpozyme 4 mg/1.1 mL powder for injectionIntravenous Cold chain | Olipudase alfa | US FDA | Available on request |
Oncology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Campath 30 mg/1 mL injectionIntravenous Cold chain | Alemtuzumab | US FDA | Available on request |
| Caprelsa 100 mg tabletOral | Vandetanib | US FDA | Available on request |
| Caprelsa 300 mg tabletOral | Vandetanib | US FDA | Available on request |
| Lemtrada 12 mg/1.2 mL injectionIntravenous Cold chain | Alemtuzumab | US FDA | Available on request |
Nephrology and urology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Renvela 2400 mg powder for oral suspensionOral | Sevelamer | US FDA | Available on request |
| Renvela 800 mg powder for oral suspensionOral | Sevelamer | US FDA | Available on request |
| Renvela 800 mg tabletOral | Sevelamer | US FDA | Available on request |
Immunology and transplant
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Aubagio 14 mg tabletOral | Teriflunomide | US FDA | Available on request |
| Aubagio 7 mg tabletOral | Teriflunomide | US FDA | Available on request |
Haematology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cablivi kit Cold chain | Caplacizumab | US FDA | Available on request |
Endocrinology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Thyrogen 0.9 mg/mL powder for injectionIntramuscular Cold chain | Thyrotropin alfa | US FDA | Available on request |
Other products
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Qfitlia 20 mg/0.2 mL injectionSubcutaneous Cold chain | Fitusiran | US FDA | Available on request |
| Qfitlia 50 mg/0.5 mL injectionSubcutaneous Cold chain | Fitusiran | US FDA | Available on request |
| Thymoglobulin 5 mg/mL powder for injectionIntravenous Cold chain | Lapine t-lymphocyte immune globulin | US FDA | Available on request |
| Wayrilz 400 mg tabletOral | Rilzabrutinib | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Genzyme
Send a request for any of these products. We confirm the licensed source, documents and lead time.